NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q3 2023 Earnings

29NovExpected
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.8
-1.2
-0.6
-0

Details

Expected EPS
-0.4864
Actual EPS
0
Surprise EPS
0.49
Surprise Percent
+100%

Description

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) will report earnings of for Q3 2023 on November 29, 2023.

0 Comments

Share your thoughts